Royce Micro-Cap Trust Files Definitive Proxy Statement

TL;DR

Royce Micro-Cap Trust filed its proxy statement for the 2025 annual meeting. Shareholders vote on company matters.

AI Summary

Royce Micro-Cap Trust, Inc. filed its definitive proxy statement on August 18, 2025, for its fiscal year ending December 31, 2025. The filing, designated as DEF 14A, pertains to the company's annual meeting and related shareholder matters. The company's principal executive offices are located at One Madison Avenue, New York, NY.

Why It Matters

This filing provides shareholders with essential information regarding the company's governance, executive compensation, and voting matters for the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not indicate any immediate financial distress or significant operational changes.

Key Numbers

• 20251008 — Conformed Period of Report (Indicates the period the filing relates to.)
• 20250818 — Filed as of Date (The date the filing was submitted to the SEC.)

Key Players & Entities

• ROYCE MICRO-CAP TRUST, INC. (company) — Registrant
• 0000912147 (company) — Central Index Key
• One Madison Avenue, New York, NY 10010 (company) — Business Address

FAQ

Filing Documents

• g110578_rmt.htm (DEF 14A) — 355KB
• image_001.jpg (GRAPHIC) — 1KB
• image_002.jpg (GRAPHIC) — 1KB
• image_003.jpg (GRAPHIC) — 1KB
• image_004.jpg (GRAPHIC) — 1KB
• image_005.jpg (GRAPHIC) — 1KB
• image_006.jpg (GRAPHIC) — 37KB
• image_007.jpg (GRAPHIC) — 5KB
• image_008.jpg (GRAPHIC) — 2KB
• image_009.jpg (GRAPHIC) — 7KB
• image_010.jpg (GRAPHIC) — 6KB
• image_011.jpg (GRAPHIC) — 1KB
• 0000949377-25-000069.txt ( ) — 445KB

financial statements be included in the Fund’s 2024 Annual Report to Stockholders

financial statements be included in the Fund’s 2024 Annual Report to Stockholders. Nominating Committee The Board has a Nominating Committee (the “Nominating Committee”) composed of the six Independent Directors, namely Ms. Chadwick, Ms. Harper, and Ms. Poston, and Messrs. Grisanti, O’Brien, and Shields. Mr. O’Brien has served as Chair of the Nominating Committee in the past, including during 2023, the last year in which it held meetings. The Board has adopted a Nominating Committee charter for the Fund, a copy of which is included as an exhibit to this Proxy Statement. A copy of the Nominating Committee charter for the Fund may also be obtained by calling 1-800-221-4268. The Nominating Committee is responsible for identifying and recommending to the Board individuals believed to be qualified to become Board members in the event that a position is vacated or created. The Nominating Committee will consider Director candidates recommended by stockholders. In considering potential nominees, the Nominating Committee will take into consideration (i) the contribution which the person can make to the Board, with consideration given to the person’s business and professional experience, education and such other factors as the Committee may consider relevant, including but not limited to whether a potential nominee’s personal and professional qualities and attributes would provide a beneficial diversity of skills, experience and/or perspective to the Board; (ii) the character and integrity of the person; (iii) whether or not the person is an “interested person” as defined in the Investment Company Act and whether the person is otherwise qualified under applicable laws and regulations to serve as a Director or Independent Director of the Fund; (iv) whether or not the person has any relationships that might impair his or her independence, such as any business, financial or family relationships with Fund management, the

View Full Filing

View this DEF 14A filing on SEC EDGAR